Bristol-Myers Squibb
BMY
#176
Rank
$129.99 B
Marketcap
$63.64
Share price
-0.17%
Change (1 day)
34.97%
Change (1 year)

Bristol-Myers Squibb (BMY) - P/B ratio

P/B ratio as of September 2026 : 6.44

According to Bristol-Myers Squibb's latest financial reports the company has a price-to-book ratio of 2.67079.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Bristol-Myers Squibb - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-315.88-17.62%
2024-12-317.14101.6%
2023-12-313.54-27.97%
2022-12-314.9227.9%
2021-12-313.843.88%
2020-12-313.7033.76%
2019-12-312.77-53.7%
2018-12-315.98-29.42%
2017-12-318.4741.7%
2016-12-315.97-24.58%
2015-12-317.9221.64%
2014-12-316.5113.76%
2013-12-315.7246.97%
2012-12-313.903.5%
2011-12-313.7630.82%
2010-12-312.88-1.43%
2009-12-312.92-22.59%
2008-12-313.77-23.94%
2007-12-314.96-4.1%
2006-12-315.1728.81%
2005-12-314.01-17.94%
2004-12-314.89-13.76%
2003-12-315.679.77%
2002-12-315.17

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.88 22.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6.71 4.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.74-72.98%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-68.9-1,170.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
32.1 397.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
22.3 246.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.21-81.27%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
1.73-73.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
7.80 21.15%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
5.21-19.07%๐Ÿ‡ฌ๐Ÿ‡ง UK